Information Library
Get to market faster - Phase IIIB/IV
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Early Phase Optimization Strategies
November 18, 2009
As payers balk at rising drug prices and patent expirations threaten the industry’s revenue streams, pharmaceutical companies worldwide are looking for ways to cut costs associated with drug development and, simultaneously, speed the process up. -
Coordinating Safety Across Functions and Phases
November 3, 2009
A customer faced significant challenges with clinical and post-marketing safety. Without previous drug safety experience, they needed an ally who could provide a full range of safety and risk management solutions. -
QUINTILES INCREASES CAPACITY TO SUPPORT EUROPEAN CLINICAL TRIALS
September 24, 2009 - Quintiles Transnational Corp. today announced the opening of an expanded regional facility near Edinburgh, Scotland. Located within the Alba Campus, a research and development center near Edinburgh, the 115,000-square-foot building hosts more than 500 employees and has space for Quintiles Clinical Development Services, including Project Management, Regulatory Affairs and Data Management. -
How to Navigate the New CDISC Standard
March 25, 2009
Quintiles – a CDISC Registered Solutions Provider – helps you get every detail right.
Page 1 of 1 (4 items)